Emma Jussing

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2025;10(1):4
Rapid fabrication and dissolution of pressed ⁵⁸Ni/Mg matrix targets for ⁵⁵Co production
Siikanen J; Milton S; Bratteby K; Lin W; Engle JW; Jussing E; Tran TA
Journal article: ANNALS OF ONCOLOGY. 2024;35:s402-s403
435TiP Molecular imaging of programmed death ligand 1 (PD-L1) expression with [89Zr]Zr-atezolizumab positron emission tomography/computed tomography (PET/CT) in patients with metastatic triple negative breast cancer (mTNBC): The MIMIR-study
Altena R; Tzortzakakis A; Blomgren A; Jussing E; Ekman S; Tran T; Axelsson R; Bergh J
Article: JOURNAL OF NUCLEAR MEDICINE. 2024;65(5):700-707
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [ 68 Ga]Ga-ABY-025: Results from a Pilot Study
Altena R; af Buren S; Blomgren A; Karlsson E; Tzortzakakis A; Brun N; Moein MM; Jussing E; Frejd FY; Bergh J; Tran TA; Hartman J; Axelsson R
Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):42
Microfluidic-based production of [⁶⁸Ga]Ga-FAPI-46 and [⁶⁸Ga]Ga-DOTA-TOC using the cassette-based iMiDEV™ microfluidic radiosynthesizer
Mallapura H; Ovdiichuk O; Jussing E; Thuy TA; Piatkowski C; Tanguy L; Collet-Defossez C; Langstrom B; Halldin C; Nag S
Article: EJNMMI RADIOPHARMACY AND CHEMISTRY. 2023;8(1):41
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [⁶⁸Ga]Ga-ABY-025 tracer
Jussing E; Ferrat M; Moein MM; Alfredeen H; Tegnebratt T; Bratteby K; Samen E; Feldwisch J; Altena R; Axelsson R; Tran TA
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108455
O-59 Preclinical evaluation of [89Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC)
Bratteby K; Smertinaite L; Omer S; Lu L; Milton S; Jussing E; Siikanen J; Samen E; Axelsson R; Foukakis T; Altena R; Tran T
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108721
P-258 First time evaluation of 45Ti for radiolabeling of NOTA and DOTA chelators
Milton S; Jussing E; Bratteby K; Ferrat M; Samen E; Tran T; Siikanen J
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:108529
P-057 Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer
Jussing E; Alfredéen H; Moein MM; Tegnebratt T; Bratteby K; Samen E; Altena R; Axelsson R; Tran T
Journal article: ANNALS OF ONCOLOGY. 2023;34:s384
Precision imaging with human epidermal growth factor receptor 2-positron emission tomography (HER2-PET) for refined treatment selection in patients with HER2-low breast cancer
af Buren S; Axelsson R; Jussing E; Karlsson M; Blomgren A; Brun N; Frejd FY; Tran TA; Altena R
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s197-s198
P-271 Preparation and cGMP-compliant production of the bombesin analogue [68Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer
Jussing E; Moein MM; Tegnebratt T; Semetaite V; Liepins E; Tzortzakakis A; Axelsson R; Orlova A; Tran T
Journal article: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:s122-s123
P-133 Automated radiolabeling of [68Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer
Chandrashekara HK; Tran T; Jussing E; Tanguy L; Långström B; Le Meunier L; Halldin C; Nag S
Article: MOLECULAR IMAGING AND BIOLOGY. 2021;23(6):952-962
Optimisation of the Synthesis and Cell Labelling Conditions for [⁸⁹Zr]Zr-oxine and [⁸⁹Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications
Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samen E; Carlsten M; Holmin S; Tran TA
Article: APPLIED RADIATION AND ISOTOPES. 2021;176:109825
Cyclotron-produced ⁶⁸Ga from enriched ⁶⁸Zn foils
Siikanen J; Jussing E; Milton S; Steiger C; Ulin J; Jonsson C; Samen E; Tran TA
Article: BIOMOLECULES. 2021;11(8):1118
Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
Jussing E; Milton S; Samen E; Moein MM; Bylund L; Axelsson R; Siikanen J; Tran TA
Article: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2021;64(8):346-352
Fully automated production of the fibroblast activation protein radiotracer [¹⁸F]FAPI-74
Dahl K; Jussing E; Bylund L; Moein MM; Samen E; Tran T
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2021;41(3):617-629
The cellular basis of increased PET hypoxia tracer uptake in focal cerebral ischemia with comparison between [¹⁸F]FMISO and [⁶⁴Cu]CuATSM
Little PV; Arnberg F; Jussing E; Lu L; Jensen AI; Mitsios N; Mulder J; Tran TA; Holmin S
Article: EJNMMI RESEARCH. 2020;10(1):106
[⁶⁸Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport
Jussing E; Lu L; Grafstrom J; Tegnebratt T; Arnberg F; Rosik HW; Wennborg A; Holmin S; Feldwisch J; Stone-Elander S
Article: EJNMMI RESEARCH. 2018;8(1):27
Hallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties
Sanchez-Crespo A; Jussing E; Bjorklund A-C; Tamm KP
Article: CELL TRANSPLANTATION. 2017;26(2):283-292
Safety of Intra-Arterial Injection With Tumor-Activated T Cells to the Rabbit Brain Evaluated by MRI and SPECT/CT
Lundberg J; Jussing E; Liu Z; Meng Q; Rao M; Samen E; Grankvist R; Damberg P; Dodoo E; Maeurer M; Holmin S
Article: CELL TRANSPLANTATION. 2016;25(2):401-410
Intra-arterial Administration of Placenta-Derived Decidual Stromal Cells to the Superior Mesenteric Artery in the Rabbit: Distribution of Cells, Feasibility, and Safety
Arnberg F; Lundberg J; Olsson A; Samen E; Jaff N; Jussing E; Dahlen U; Nava S; Axelsson R; Ringden O; Kaipe H; Holmin S
Article: CLINICAL NUCLEAR MEDICINE. 2012;37(4):362-365
Normal Uptake of ⁶⁸Ga-DOTA-TOC by the Pancreas Uncinate Process Mimicking Malignancy at Somatostatin Receptor PET
Jacobsson H; Larsson P; Jonsson C; Jussing E; Gryback P
Visa fler

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2023
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [68Ga]Ga-ABY-025 tracer
Jussing E; Ferrat M; Moein MM; Alfredéen H; Tegnebratt T; Bratteby K; Samén E; Feldwisch J; Altena R; Axelsson R; Tran TA
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:S244-S245
First time evaluation of ⁴⁵Ti for radiolabeling of NOTA and DOTA chelators
Milton S; Jussing E; Bratteby K; Ferrat M; Samen E; Tran T; Siikanen J
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:S46
Preclinical evaluation of [⁸⁹Zr]Zr-DFO*-sacituzumab, a PET tracer for imaging of whole body TROP-2 expression as a potential selection tool for treatment with TROP-2 antibody drug conjugates (ADC)
Bratteby K; Smertinaite L; Omer S; Lu L; Milton S; Jussing E; Siikanen J; Samen E; Axelsson R; Foukakis T; Altena R; Tran T
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2023;126:S99-S100
Optimized, automated and cGMP-compliant synthesis of the HER2 targeting [⁶⁸Ga]Ga-ABY-025 tracer
Jussing E; Alfredeen H; Moein MM; Tegnebratt T; Bratteby K; Samen E; Altena R; Axelsson R; Tran T
Corrigendum: MOLECULAR IMAGING AND BIOLOGY. 2022;24(3):510
Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications (vol 23, pg 952, 2021)
Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samen E; Carlsten M; Holmin S; Tran TA
Doctoral thesis: 2022
Development of radiometal-based labelling techniques and tracers for non-invasive molecular imaging
Jussing EC
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S122-S123
Automated radiolabeling of [⁶⁸Ga]Ga-DOTATOC using the iMiDEV™ automated microfluidic radiosynthesizer
Chandrashekara HK; Thuy T; Jussing E; Tanguy L; Langstrom B; Le Meunier L; Halldin C; Nag S
Conference publication: NUCLEAR MEDICINE AND BIOLOGY. 2022;108:S197-S198
Preparation and cGMP-compliant production of the bombesin analogue [⁶⁸Ga]Ga-NOTA-RM26 for first-in-human clinical study of gastrin-releasing peptide receptor expression in prostate cancer
Jussing E; Moein MM; Tegnebratt T; Semetaite V; Liepins E; Tzortzakakis A; Axelsson R; Orlova A; Thuy T
Conference publication: JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. 2019;62:S551-S552
Optimization of ⁸⁹Zr-based radiotracers for long-term in vivo cell tracking with PET imaging
Jonsson I; Jussing E; Zhang X-M; Lu L; Samen E; Harris R; Holmin S; Thuy T
Preprint: MEDRXIV.
Molecular PD-L1 PET/CT Imaging with 89Zr-atezolizumab to Monitor Immune Responses in metastatic Triple Negative Breast Cancer: study protocol for a phase II diagnostic imaging trial
Altena R; Tran TA; Kjällquist U; Karlsson M; Siikanen J; Jussing E; Tzortzakakis A; Jonmarker O; Axelsson R; Bergh J

Anställningar

Postdoctoral Studies, Onkologi-Patologi, Karolinska Institutet, 2025-2026
Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2022

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI